Novocure Ltd. NVCR on Thursday reported topline results from its Phase 3 TRIDENT study. The data showed that starting Tumor ...

People diagnosed with recurrent IDH-mutant grade 3 astrocytoma, a rare and aggressive brain cancer, lived roughly 11 months ...

For most children, kicking a soccer ball around the backyard is an everyday activity. For 6-year-old Hadley McMahon, it's ...

Glioblastoma claims the lives of 200,000 people each year globally. Despite decades of research and funding, survival rates ...

Glioblastoma-the most aggressive form of brain cancer-remains one of medicine's biggest challenges. Despite surgery, radiotherapy, and chemotherapy, most patients survive only about a year after ...

Nine months after undergoing surgery to remove a malignant brain tumor, Severiano Ballesteros, a prominent Spanish golfer, yesterday announced a new cancer foundation, reports the Associated Press. Mr ...

Patients who received a focused ultrasound treatment to aid drug delivery increased their odds of surviving the deadliest form of brain cancer by nearly 40%, according to a study led by University of ...

Novocure (NVCR) stock plunges as the company annouces a late-stage trial setback for its cancer treatment device, Tumor ...

An unexpected lab observation has led a team of scientists to discover how diet can influence survival in animal models of ...

Jeannine Walston, who has contributed to CURE since 2015, was diagnosed with a brain tumor in March 1998. Jeannine Walston has a survivorship story of more than 25 years to share. Walston, who has ...

The 2024 Australian of the Year Professor Richard Scolyer has died. In his final message he urged all Australians to "pursue ...